Overview

Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

Status:
COMPLETED
Trial end date:
2025-08-22
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 receptor agonists.
Phase:
PHASE2
Details
Lead Sponsor:
Veru Inc.
Treatments:
ostarine
semaglutide